Annexon says enrollment of Phase 3 Archer II Trial expected to be completed in Q3 2025

RefinitivMeno di 1 minuto di lettura

Annexon Inc ANNX:

ANNEXON INC - ENROLLMENT OF PHASE 3 ARCHER II TRIAL EXPECTED TO BE COMPLETED IN Q3 2025, WITH TOPLINE DATA EXPECTED IN SECOND HALF OF 2026

© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html

Accedi o crea un account gratuito per leggere queste notizie